Hrt Financial LP Esperion Therapeutics, Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$2.02 - $3.02 $795,999 - $1.19 Million
394,059 Added 821.45%
442,030 $1.18 Million
Q4 2023

Feb 09, 2024
SELL
$0.73 - $3.08 $13,723 - $57,900
-18,799 Reduced 28.15%
47,971 $143,000
Q3 2023

Nov 13, 2023
SELL
$0.96 - $1.79 $416,639 - $776,858
-433,999 Reduced 86.67%
66,770 $65,000
Q2 2023

Aug 11, 2023
BUY
$1.2 - $1.76 $577,615 - $847,168
481,346 Added 2478.23%
500,769 $696,000
Q1 2023

May 12, 2023
SELL
$1.46 - $7.3 $632 - $3,160
-433 Reduced 2.18%
19,423 $30,000
Q4 2022

Feb 10, 2023
SELL
$5.09 - $8.5 $134,065 - $223,881
-26,339 Reduced 57.02%
19,856 $123,000
Q3 2022

Nov 14, 2022
BUY
$5.45 - $8.13 $69,373 - $103,486
12,729 Added 38.04%
46,195 $309,000
Q2 2022

Aug 12, 2022
BUY
$4.77 - $6.67 $159,632 - $223,218
33,466 New
33,466 $212,000
Q1 2022

May 16, 2022
SELL
$3.34 - $5.56 $786,486 - $1.31 Million
-235,475 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$4.81 - $11.92 $244,304 - $605,428
50,791 Added 27.5%
235,475 $1.18 Million
Q3 2021

Nov 15, 2021
BUY
$11.34 - $21.37 $2.09 Million - $3.95 Million
184,684 New
184,684 $2.23 Million
Q1 2020

May 15, 2020
SELL
$27.44 - $73.84 $187,278 - $503,958
-6,825 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$35.4 - $59.82 $241,605 - $408,271
6,825 New
6,825 $406,000

Others Institutions Holding ESPR

# of Institutions
210
Shares Held
129M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $119M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email